Skip to content

Prospective evaluation of an AR-based method for transcutaneous procedures in interventional radiology

Prospective evaluation of an AR-based method for transcutaneous procedures in interventional radiology

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00034408
Enrollment
100
Registered
2024-06-14
Start date
2024-07-24
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CT-guided percutaneous biopsy of the liver

Interventions

Group 1: Percutaneous biopsy with the AR system Group 2: Percutaneous biopsy with CT-fluoroscopy

Sponsors

Universitätslinik für Radiologie und Nuklearmedizin Magdeburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: -patients with CT-assisted transcutaneous punctures of the liver, with indication for liver biopsy -written informed consent of the study participant

Exclusion criteria

Exclusion criteria: -patients under the age of 18 -pregnant patients -contraindications for sonography or CT imaging, or biopsies performed with these procedures -uncontrollable intolerance to contrast agent

Design outcomes

Primary

MeasureTime frame
-comparison of radiation exposure of patient and staff, based on the dose values output by the CT.

Secondary

MeasureTime frame
-comparison of the intervention time (incision to suture time) -Comparison of the set-up time (door to incision time) -comparison of complications, evaluation according to the CTCAE-classification for surgical and medical procedures

Countries

Germany

Contacts

Public ContactKarl Rohmer

Universitätslinik für Radiologie und Nuklearmedizin Magdeburg

karl.rohmer@med.ovgu.de+49 391 67-13030

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026